Summary & Overview
CPT 92012: Intermediate Ophthalmologic Exam for Established Patients
CPT 92012 designates an intermediate-level ophthalmologic examination and evaluation for established patients, including initiation or continuation of a diagnostic and treatment program. It is widely used in routine eye-care management for conditions that require focused assessment and plan adjustments without the full scope of a comprehensive exam. Nationally, this code is important for coding consistency across outpatient ophthalmology practices and for proper capture of evaluation-and-management work performed during follow-up and intermediate visits. Key payers included in the coverage discussion are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise description of the code’s clinical intent, typical site of service, common associated diagnoses, relevant companion and ancillary CPT/HCPCS codes, and common modifiers used in practice workflows. The publication outlines payer coverage considerations and coding relationships to procedures frequently performed in ophthalmic follow-up care. It also provides context for selecting CPT 92012 versus related ophthalmology codes and summarizes the administrative elements that affect billing and documentation. Data not available in the input for service line metadata is noted where applicable.
CPT Code Overview
CPT 92012 describes ophthalmological services consisting of a medical examination and evaluation with initiation or continuation of a diagnostic and treatment program for an established patient at an intermediate level. This service falls under the Ophthalmology – General Ophthalmological Services and Procedures service line. Typical site of service is the office (POS 11).
Clinical & Coding Specifications
Clinical Context
A 68-year-old established patient with progressive difficulty reading and intermittent blurred vision presents to an ophthalmology office for routine follow-up. The visit occurs in an office setting (POS 11). The clinician documents a focused history of visual symptoms, medication and ocular history review, visual acuity testing, intraocular pressure measurement, slit-lamp anterior segment examination, and dilated fundus exam. The clinician updates the diagnostic and treatment plan, which may include spectacle prescription change for presbyopia, glaucoma medication adjustment, or monitoring of visual disturbances. If a separately identifiable evaluation and management service is provided on the same day as a procedure, appropriate modifier use is documented.
Coding Specifications
-
Modifiers
-
25: Significant, Separately Identifiable Evaluation and Management Service by the Same Physician on the Same Day of the Procedure or Other Service — used when the ophthalmological E/M documented for the visit is separate and above the usual pre- and post-procedure work for a same-day procedure. -
59: Distinct Procedural Service — used when a procedure performed on the same day is distinct or independent from other services provided on the same date of service. -
Provider Taxonomies
| Taxonomy Code | Specialty |
|---|---|
207W00000X | Ophthalmology Physician |
152W00000X | Optometrist |
207WX0009X | Glaucoma Specialist |
-
Notes on use
-
Use
25when documentation supports an E/M that is separately identifiable from same-day procedural care. -
Use
59when procedural CPTs performed the same day are distinct services with separate anatomic or procedural bases. -
If additional components (professional vs technical) were relevant, those modifiers would be used; none were provided in the input.
Related Diagnoses
H52.4— Presbyopia
Presbyopia is age-related loss of near focusing and is relevant to refractive assessment and potential spectacle changes documented during an established ophthalmological evaluation coded as 92012.
H40.9— Unspecified glaucoma
Glaucoma is monitored by intraocular pressure checks and optic nerve/visual field assessment during follow-up visits; 92012 may be used when ongoing glaucoma management and medication adjustment are part of the evaluation.
H53.9— Unspecified visual disturbance
Visual disturbances such as transient blurring or metamorphopsia are evaluated during the intermediate established patient exam represented by 92012 to determine diagnostic and treatment plans.
H54.7— Unspecified visual loss
Documented visual loss prompts focused assessment and monitoring; 92012 applies when the visit addresses continuation of a diagnostic/treatment program for established patients with vision loss.
Z01.00— Encounter for examination of eyes and vision without abnormal findings
Routine eye and vision examinations without abnormal findings can be coded under 92012 for established patient visits when the encounter matches intermediate-level ophthalmological evaluation and management.
Related CPT Codes
| CPT Code | Description | Relationship to 92012 |
|---|---|---|
92014 | Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; comprehensive, established patient, 1 or more visits | Alternative for a more comprehensive established patient exam; may be selected instead of 92012 when encounter is comprehensive. |
92285 | External ocular photography with interpretation and report for documentation of medical progress (eg, close‑up photography, slit lamp photography, goniophotography, stereo‑photography) | Adjunct diagnostic documentation often used in follow-up or monitoring alongside 92012. |
95874 | Needle electromyography for guidance in conjunction with chemodenervation | Potential concurrent service when electromyography guidance is required for ocular injections that may occur in the same episode of care. |
96372 | Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | Concurrent procedure for injections administered during the visit; may be billed separately when documented as distinct. |
J0585 | Injection, onabotulinumtoxina, 1 unit | Supply/J-code for a neurotoxin that may be administered during an ophthalmology visit in conjunction with procedural codes. |
J0586 | Injection, abobotulinumtoxina, 5 units | Supply/J-code similar context as J0585. |
J0587 | Injection, rimabotulinumtoxinb, 100 units | Supply/J-code similar context as J0585. |
J0588 | Injection, incobotulinumtoxina, 1 unit | Supply/J-code similar context as J0585. |
-
Common usage notes
-
92285is often used together with92012when photographic documentation is required for disease monitoring. -
Injection codes such as
96372and associated J-codes may be billed together with92012when injections are administered and documentation supports distinct services; appropriate modifiers (for example25or59) may be required based on documentation.
National Reimbursement Benchmarks
National commercial averages (BUCA) at $88.51 are modestly below Medicare at $94.06 in mean allowed rate for code 92012. UnitedHealth Group and Cigna show the highest commercial means at $113.26 and $109.25 respectively, while Aetna and Blue Cross Blue Shield are clustered near $79.
Dispersion measured as the interquartile range (P75 − P25) varies across payers: Cigna and UnitedHealth Group have the widest spreads (Cigna: $65.00, UHC: $61.83), indicating greater variability; Medicare and BCBS are among the tightest (Medicare: $9.00, BCBS: $33.75). The table and chart below present the full breakdown.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.